Alzheimer’s disease (AD) is a multifactorial disease, with amyloid beta (Abeta) accumulation in the brain as one of the first detectable pathological hallmarks [1–3] in concert with accumulating tau pathology, neuronal damage, synapse loss, and inflammation [1]. This evidence concerns the gene MAPT and Alzheimer disease.